UBS Group’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $137K | Sell |
|
|||||
|
2025
Q2 | $818K | Sell |
|
|||||
|
2025
Q1 | $1.4M | Buy |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2024
Q3 | $1.9M | Sell |
|
|||||
|
2024
Q2 | $1.87M | Sell |
|
|||||
|
2024
Q1 | $5.69M | Buy |
|
|||||
|
2023
Q4 | $1.57M | Sell |
|
|||||
|
2023
Q3 | $598K | Buy |
|
|||||
|
2023
Q2 | $742K | Buy |
|
|||||
|
2023
Q1 | $511K | Sell |
|
|||||
|
2022
Q4 | $1.59M | Sell |
|
|||||
|
2022
Q3 | $2.78M | Sell |
|
|||||
|
2022
Q2 | $2.62M | Buy |
|
|||||
|
2022
Q1 | $8M | Sell |
|
|||||
|
2021
Q4 | $11M | Sell |
|
|||||
|
2021
Q3 | $18.6M | Buy |
|
|||||
|
2021
Q2 | $15.2M | Buy |
|
|||||
|
2021
Q1 | $9.71M | Buy |
|
|||||
|
2020
Q4 | $3.34M | Buy |
|